Top Markets
#1 ADO Protocol ADO Protocol +335.18%
#2 GoPlus Security GoPlus Security +42.11%
#3 Starpower Starpower +31.42%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +26.15%
#5 GAIB AID GAIB AID +24.67%
#6 The Black Bull The Black Bull +17.94%
#7 Nockchain Nockchain +14.81%
#8 DMT-NAT DMT-NAT +14.09%
#9 Provenance Blockchain Provenance Blockchain +12.69%
#10 Euler Euler +12.61%
Coin of the day
ADO Protocol ADO Protocol
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
NeoImmuneTech, Inc. NeoImmuneTech, Inc.

NeoImmuneTech, Inc.

950220
Classement en actions #33507
As a clinical-stage biotechnology firm with a strong focus on T cells,... As a clinical-stage biotechnology firm with a strong focus on T cells, NeoImmuneTech, Inc. is dedicated to creating and marketing innovative immunotherapies. The company's lead product, NT-I7, is a long-acting human IL-7 currently in clinical development for its potential to treat a range of oncologic and infectious conditions. Founded in 2014, NeoImmuneTech is based in Rockville, Maryland.
Prix de l'action
$1.12
Dernière synchronisation: 2026-08-14
Capitalisation boursière
$7.52M
Changement (1 jour)
4.51%
Changement (1 an)
-94.79%
Pays
US
Échange NeoImmuneTech, Inc. (950220)

Catégorie

Healthcare
Ratio P/S pour NeoImmuneTech, Inc. (950220)
Ratio P/S au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de NeoImmuneTech, Inc., le ratio cours/ventes actuel (TTM) est 0. À la fin de 2026, le ratio P/S était de 0.
Historique du ratio P/S pour NeoImmuneTech, Inc. de 2026 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
Pas assez de données pour les dates fournies.
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE